|
KIF16B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.90299999986077E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59499999985435E-07 |
| Normal-vs-Stage2 |
1.695910E-02 |
| Normal-vs-Stage3 |
5.417200E-03 |
| Normal-vs-Stage4 |
1.435260E-04 |
| Stage1-vs-Stage2 |
6.193400E-01 |
| Stage1-vs-Stage3 |
5.990000E-01 |
| Stage1-vs-Stage4 |
5.359400E-01 |
| Stage2-vs-Stage3 |
9.823400E-01 |
| Stage2-vs-Stage4 |
4.652000E-01 |
| Stage3-vs-Stage4 |
4.636800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.21529999952408E-07 |
| Normal-vs-AfricanAmerican |
3.403700E-04 |
| Normal-vs-Asian |
2.137700E-02 |
| Caucasian-vs-AfricanAmerican |
3.252800E-01 |
| Caucasian-vs-Asian |
7.783400E-01 |
| AfricanAmerican-vs-Asian |
9.458400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.877199999889E-07 |
| Normal-vs-Female |
2.212300E-04 |
| Male-vs-Female |
3.160000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.77770000000211E-05 |
| Normal-vs-Extreme_Weight |
9.60990000020701E-07 |
| Normal-vs-Obese |
8.038500E-04 |
| Normal-vs-Extreme_Obese |
1.757860E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.410400E-01 |
| Normal_Weight-vs-Obese |
3.120000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.678800E-01 |
| Extreme_Weight-vs-Obese |
9.363700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.699000E-01 |
| Obese-vs-Extreme_Obese |
1.695030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.059800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.992000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.41070000125865E-08 |
| Normal-vs-Age(81-100Yrs) |
2.2679000000192E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.435600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.125800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.621500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.497600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.691900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.262800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.37939999994763E-06 |
| Normal-VS-Type2 PRCC |
3.38529999999171E-06 |
| Normal-VS-KIRP CIMP |
7.52550000000518E-05 |
| Normal-VS-Unclassified PRCC |
4.841600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.962600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.752000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.645200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.384000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.802240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.990000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.43619999998435E-06 |
| Normal-vs-N1 |
3.152600E-04 |
| Normal-vs-N2 |
1.843140E-03 |
| N0-vs-N1 |
6.305400E-01 |
| N0-vs-N2 |
5.542800E-01 |
| N1-vs-N2 |
3.501000E-01 |
|
|
